Clobazam Suspension
Product Images NDC 62135-527
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 62135-527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Clobazam-figure-1 (Clobazam Figure 1)
Clobazam-figure-2 (Clobazam Figure 2)
This text represents a chart or graph showing the percentage of patients in different treatment groups for a certain condition, along with their improvement in weekly drop seizure frequency from baseline. The treatment groups include a Placebo, Clobazam Low, Medium, and High. The chart also shows the range of reduction in weekly drop seizure frequency from baseline.*
Clobazam-figure-a (Clobazam Figure A)
Clobazam-figure-b (Clobazam Figure B)
Clobazam-figure-c (Clobazam Figure C)
Clobazam-figure-d (Clobazam Figure D)
Clobazam-structure-formula.jpg (Clobazam Structure Formula)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.